Veeva Systems Inc. (VEEV)

NYSE • Currently up 0.49 (+0.15%) in today's trading session

6 members of Congress have disclosed 17 trades in Veeva Systems Inc. (VEEV) via STOCK Act filings. The most recent disclosure was a purchase by Robert P. Bresnahan on 29 May 2025. The most active traders have been William R. Keating (5), Josh Gottheimer (4), and John James (3). Aggregate disclosed activity totals roughly $64K in purchases and $64K in sales (midpoint estimates from bracketed disclosure amounts).

Veeva Systems Inc. is currently trading at $323.04, positioned at 98% of its 52-week range ($148.05 – $325.99).

Want to automatically copy Pelosi trades?

Mirror Nancy Pelosi's portfolio with just one click on eToro.

Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.

Past Performance is not an indication of future results.

Current Price
$323.04
24h Change
+0.49 (+0.15%)
52 Week Range
$148.05–$325.99
View on NASDAQ

Veeva Systems Inc. Price History and Technical Analysis

Interactive Chart

Congressional Trading Activity for VEEV

Select to highlight on chart
5 transactions
Compliance: 65%
Robert P. Bresnahan29 May 202523 Jun 2025PurchaseStock$1,001 - $15,000N/A
Robert P. Bresnahan16 May 20259 Jun 2025SaleStock$1,001 - $15,000N/A
William R. Keating4 Apr 202514 Jul 2026SaleStock$1,001 - $15,000N/A
Byron Donalds20 Mar 202514 Apr 2025SaleStock$1,001 - $15,000N/A
Byron Donalds20 Mar 202514 Apr 2025SaleStock$1,001 - $15,000N/A

See every trade

Sign in free to see the full trade history for this stock.

Select transactions to view their annotations on the chart

Stock Overview

Market Data

Market Cap

$52.3B

Volume

1.37M

Beta

0.93

P/E Ratio

38.78

Fundamentals

EPS

$8.33

Div. Yield

-

Open

$321.00

Day Range

$319.64 – $324.76

Company Information

Sector
Technology
Industry
Software - Application
Exchange
NYSE · USD
Country
US
CEO
Peter Gassner
IPO Date
2013-10-16

Veeva Systems Inc. is a leading provider of cloud-based software solutions, exclusively dedicated to the global life sciences industry. Its extensive operational presence spans across North America, Europe, the Asia Pacific region, the Middle East, A...

Earnings

Next Report

Q3 2026

25 Nov

EPS Est.

$2.33

Rev. Est.

$935M

Days Until

32

Recent Quarters

Q2 202626 Aug
EPS$2.35
Beat 5.4%
Q1 20263 Jun
EPS$2.24
Beat 4.7%
Q4 20254 Mar
EPS$2.06
Beat 6.2%
Q3 202520 Nov
EPS$2.04
Beat 4.6%
Q2 202527 Aug
EPS$1.99
Beat 4.7%
Q1 202528 May
EPS$1.97
Beat 13.2%
Q4 20245 Mar
EPS$1.74
Beat 8.8%
Q3 20245 Dec
EPS$1.75
Beat 10.8%
Q2 202428 Aug
EPS$1.62
Beat 5.9%
Q1 202430 May
EPS$1.50
Beat 5.6%
Q4 202329 Feb
EPS$1.38
Beat 6.2%
Q3 20236 Dec
EPS$1.34
Beat 4.7%
Q2 202330 Aug
EPS$1.21
Beat 8.0%
Q1 202331 May
EPS$0.91
Beat 15.2%
Q4 20221 Mar
EPS$1.15
Beat 10.6%
Q3 20221 Dec
EPS$1.13
Beat 5.6%
Q2 202231 Aug
EPS$1.03
Beat 2.0%
Q1 20221 Jun
EPS$0.99
Beat 7.6%
Q4 20212 Mar
EPS$0.90
Beat 2.3%
Q3 20211 Dec
EPS$0.97
Beat 10.2%
Q2 20211 Sept
EPS$0.94
Beat 9.3%
Q1 202127 May
EPS$0.91
Beat 16.7%
Q4 20202 Mar
EPS$0.78
Beat 14.7%
Q3 20201 Dec
EPS$0.78
Beat 14.7%
Q2 202027 Aug
EPS$0.72
Beat 12.5%
Q1 202028 May
EPS$0.66
Beat 13.8%
Q4 20193 Mar
EPS$0.54
Beat 3.9%
Q3 201926 Nov
EPS$0.60
Beat 11.1%
Q2 201927 Aug
EPS$0.55
Beat 12.2%
Q1 201929 May
EPS$0.50
Beat 11.1%
Q4 201826 Feb
EPS$0.45
Beat 12.5%
Q3 201828 Nov
EPS$0.45
Beat 18.4%
Q2 201823 Aug
EPS$0.39
Beat 14.7%
Q1 201824 May
EPS$0.33
Beat 10.0%
Q4 201727 Feb
EPS$0.23
Beat 9.5%
Q3 20175 Dec
EPS$0.25
Beat 13.6%
Q2 201724 Aug
EPS$0.23
Beat 15.0%
Q1 201725 May
EPS$0.22
Beat 22.2%
Q4 201628 Feb
EPS$0.22
Beat 29.4%
Q3 201622 Nov
EPS$0.22
Beat 37.5%
Q2 201630 Aug
EPS$0.15
Beat 15.4%
Q1 201626 May
EPS$0.15
Beat 36.4%
Q4 20151 Mar
EPS$0.15
Beat 36.4%
Q3 201524 Nov
EPS$0.12
Beat 9.1%
Q2 201527 Aug
EPS$0.13
Beat 18.2%
Q1 201528 May
EPS$0.12
Beat 20.0%
Q4 20143 Mar
EPS$0.12
Beat 33.3%
Q3 201425 Nov
EPS$0.09
Beat 12.5%
Q2 201428 Aug
EPS$0.09
Beat 28.6%
Q1 201429 May
EPS$0.07
Beat 16.7%
Q4 20134 Mar
EPS$0.07
Beat 16.7%
Q3 20135 Dec
EPS$0.06
Beat 20.0%

6 politicians traded within 30 days

No dividend data available for this stock.

No stock split data available for this stock.

Similar Stocks

Based on congressional trading patterns

Smart Recommendations

MSFT

Microsoft Corporation

101
$524.51+3.43 (+0.66%)
Technology
3 politicians hold this stock
Same sector: Technology
+1 more reason
3 politicians
View Stock

NVDA

NVIDIA Corporation

63
$210.96-1.25 (-0.59%)
Technology
2 politicians both hold this
Same sector: Technology
+1 more reason
2 politicians
View Stock

AMD

Advanced Micro Devices, Inc.

61
$516.79+8.86 (+1.74%)
Technology
2 politicians both hold this
Same sector: Technology
2 politicians
View Stock

Frequently Asked Questions about VEEV

Which members of Congress have traded VEEV?
6 members of Congress have disclosed 17 trades in Veeva Systems Inc. (VEEV) under the STOCK Act. The most active traders are William R. Keating, Josh Gottheimer, and John James.
When was VEEV most recently disclosed by Congress?
The most recent VEEV disclosure was a purchase by Robert P. Bresnahan on 29 May 2025.
What is the total disclosed congressional trading volume for VEEV?
Members of Congress have disclosed approximately $64K in VEEV purchases and $64K in sales. These figures are midpoint estimates derived from the bracketed amount ranges used in STOCK Act filings.
How can I track new congressional trades in VEEV?
This VEEV page updates as soon as new STOCK Act disclosures are filed for Veeva Systems Inc.. Every trade, politician, transaction date and amount range is surfaced above, typically within hours of the official filing appearing on the House or Senate disclosure portals.
Pelosi Tracker
© 2026 - All rights reserved. Powered by Vantara Labs
Pelosi Tracker is an independent, third-party platform. It is not affiliated with, endorsed by, or in any way associated with Nancy Pelosi, her office or her representatives, or with any other member of Congress. Any use of her name is solely for the purpose of discussing publicly available information.The information provided by Pelosi Tracker is for informational and educational purposes only and is not intended to serve as, nor should it be construed as, financial or investment advice. The data presented here is sourced from publicly available filings and records. While we strive for accuracy, timeliness, and completeness, we do not guarantee that all information is error-free or current.